These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 1023344

  • 1. [Clinical study of dantrolene sodium in the treatment of spastic and dystonic syndromes].
    Fraioli B, Guglielmi G, Baldassarre L.
    Riv Neurol; 1976; 46(4):333-50. PubMed ID: 1023344
    [Abstract] [Full Text] [Related]

  • 2. [Sodium dantrolene (dantrium) in the treatment of neurogenic muscular spasm].
    Couto B, Figuereido HB, Araújo Leitão RE, Alvarenga H, Gomes Marleide M, Melo Reis CH.
    Neurol Neurocir Psiquiatr; 1976; 17(4):213-21. PubMed ID: 1018726
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dantrolene sodium: long-term effects in patients with muscle spasticity.
    Joynt RL.
    Arch Phys Med Rehabil; 1976 May; 57(5):212-7. PubMed ID: 776122
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effects of dantrolene sodium on pyramidal hypertonia. Clinico-electrophysiological study].
    Caruso G, Fels A, Santoro L, Perretti A.
    Acta Neurol (Napoli); 1977 May; 32(6):872-83. PubMed ID: 343514
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of dantrolene sodium in the treatment of spasticity.
    Chipman M, Kaul S, Lambie M.
    Dis Nerv Syst; 1974 Sep; 35(9):427-31. PubMed ID: 17894068
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity].
    Ladd HW, Gingras G, Boucher J, Kazdan N, Keenan R.
    Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244
    [No Abstract] [Full Text] [Related]

  • 12. Spasticity and the effect of dantrolene sodium.
    Monster AW.
    Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132
    [No Abstract] [Full Text] [Related]

  • 13. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
    Pinder RM, Brogden RN, Speight TM, Avery GS.
    Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease.
    Weiser R, Terenty T, Hudgson P, Weightman D.
    Practitioner; 1978 Jul; 221(1321):123-7. PubMed ID: 366589
    [No Abstract] [Full Text] [Related]

  • 16. Objective assessment of spasticity, strength, and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized double-blind study.
    Katrak PH, Cole AM, Poulos CJ, McCauley JC.
    Arch Phys Med Rehabil; 1992 Jan; 73(1):4-9. PubMed ID: 1729971
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam.
    Schmidt RT, Lee RH, Spehlmann R.
    Trans Am Neurol Assoc; 1975 Jan; 100():235-7. PubMed ID: 1226625
    [No Abstract] [Full Text] [Related]

  • 19. [Botulin toxin as treatment for spasticity and dystonia in infantile cerebral paralysis].
    Aguilar-Rebolledo F, Hernández-Sánchez J, Rayo-Mares D, Soriano-Fonseca F, García-Muñoz L, Ruiz-Ponce J, Garrido-Ramírez E.
    Gac Med Mex; 2001 Jan; 137(5):403-11. PubMed ID: 11692809
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.